Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
Clinical trials that evaluate new anti-tubercular drugs and treatment regimens take years to complete due to the slow clearance of Mycobacterium tuberculosis infection and the lack of early biomarkers that predict treatment outcomes. Host Inflammation markers have been associated with tuberculosis (...
Main Authors: | Pryscila Miranda, Leonardo Gil-Santana, Marina G Oliveira, Eliene D D Mesquita, Elisangela Silva, Anneloek Rauwerdink, Frank Cobelens, Martha M Oliveira, Bruno B Andrade, Afrânio Kritski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5383283?pdf=render |
Similar Items
-
Significance of extremely elevated ferritin level in medical inpatients
by: Vardi Moshe, et al.
Published: (2014-02-01) -
Emergência de tuberculose resistente: renovado desafio Multidrug-resistant tuberculosis emergence: a renewed challenge
by: Afrânio Lineu Kritski
Published: (2010-04-01) -
The successes and lessons of a Dutch University Hospitals’ eHealth program: An evaluation study protocol
by: Anneloek Rauwerdink, et al.
Published: (2021-01-01) -
Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease
by: Melanie D. Beaton, et al.
Published: (2014-05-01) -
Inflammatory and immunogenetic markers in correlation with pulmonary tuberculosis
by: Beatriz Lima Alezio Muller, et al.
Published: (2013-12-01)